Trial intelligence / Profile preview

Vitamin D supplementation for prevention of placenta-mediated pregnancy complications

2010-019483-37Phase 4Active

Sponsor
Karolinska University Hospital
Start
Jun 2010
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of vitamin d in preeclampsia, intrauterine growth restriction (IUGR), preterm birth and 1 more, sponsored by Karolinska University Hospital. Primary endpoints: Incidence of placental-related pregnancy complications, Umbilical artery blood flow and 4 more. Started Jun 2010; status: active.

02

Drugs

vitamin d
03

Conditions

preeclampsiaintrauterine growth restriction (IUGR)preterm birthPlacenta-mediated pregnancy complication (PMPC)

Beyond the preview

Go deeper on 2010-019483-37.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-019483-37.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call